vaccination failure/1st dose 8may2021/2nd dose 19jun2021/sars-cov-2 test: (28oct2021) positive; sars-cov-2 infection/sars-cov-2 test: (28oct2021) positive; this is a spontaneous report received from a contactable reporter(s) (physician) from a regulatory authority. regulatory number: at-basgages-2022-015074. this case is one of w two reports. this report is for the lack of efficacy report. a 60 year-old female patient received bnt162b2 (comirnaty), intramuscular, administration date 19jun2021 (lot number: fd0168) as dose 2, single and intramuscular, administration date 08may2021 (lot number: ey3014) as dose 1, single for covid-19 immunisation. the patient's relevant medical history and concomitant medications were not reported. the following information was reported: drug ineffective (medically significant) with onset 28oct2021, outcome "unknown", described as "vaccination failure/1st dose 8may2021/2nd dose 19jun2021/sars-cov-2 test: (28oct2021) positive"; covid-19 (medically significant) with onset 28oct2021, outcome "unknown", described as "sars-cov-2 infection/sars-cov-2 test: (28oct2021) positive". the patient underwent the following laboratory tests and procedures: sars-cov-2 test: (28oct2021) positive, notes: variant pcr-based: n.a.variant sequenced: n.a.n501y-positive: unknown. no follow-up attempts are possible. no further information is expected.; sender's comments: linked report(s) : at-pfizer inc-202200287757 same reporter, same patient, different dose, different events

test date: 20211028; test name: covid-19 pcr test; test result: positive ; comments: variant pcr-based: n.a. variant sequenced: n.a. n501y-positive: unknown

na

na